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Abstract. 
Primary hepatic adenosquamous carcinoma (ASC), a variant cholangiocellular carcinoma 
(CCC) subtype, is rare with very poor prognosis. It is difficult to diagnosis only with a serum 
marker and imaging study. We reported a case of primary hepatic ASC presenting with ab-
dominal discomfort and fever. According to clinical features and imaging studies, liver abscess 
was diagnosed initially. After further evaluation, hepatic tumor with peritoneal carcinomatosis 
was suspected; biopsy of the hepatic tumor revealed carcinoma with both glandular and squa-
mous differentiation, findings compatible with ASC. Because no other primary site was found 
for malignancy, primary hepatic ACS with peritoneal carcinomatosis was diagnosed. This pa-
tient succumbed from multiple organ failure 1 month after the diagnosis. 
 
Keywords : primary hepatic adenosquamous carcinoma, cholangiocellular carcinoma, 
peritoneal carcinomatosis, liver abscess 
病例報告  
疑似肝膿瘍的原發性肝臟腺鱗狀癌合併腹膜轉移 
楊國鑫 1,2 施壽全 1,2 王鴻源 1,2 陳銘仁 1,2 林錫泉 1,2* 
1馬偕紀念醫院 腸胃內科 
2馬偕醫護管理專科學校 
中文摘要 
  原發性肝臟腺鱗癌是屬於膽道細胞癌的一種，腫瘤中同時有腺癌的分化也有鱗狀上
皮癌的分化，相當少見，目前沒有辦法利用病人的症狀、抽血檢查及影像學檢查就可以
直接診斷，必須要靠病理切片才能確診，治療以開刀合併化療為主，預後非常差，大多
數的病人在確診後一年內都會死亡。我們這次是要報告一位原發性肝臟腺鱗癌的案例，
一開始根據病人的初始症狀(腹部不適、發燒)及影像學檢查疑似病人有肝膿瘍，但後來經
過更進一步的檢查後，確定病人有原發部位不明的轉移癌，在無法找到原發腫瘤的情況
下，對肝臟的病灶做切片，最後確定是原發性肝臟腺鱗癌合併多處轉移，雖然確診後立
刻接受化療的治療，但病人仍於確診後一個月死亡。我們回顧文獻探討此類複雜病況的
策略。 
 
關鍵字: 原發性肝臟腺鱗癌、膽道細胞癌、腹膜癌、肝膿瘍 
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INTRODUCTION 
Primary malignant tumors in the liver include 
hepatocellular carcinoma (HCC), cholangiocarcinoma 
(CCC), mixed tumors, sarcoma, hepatoblastoma, 
lymphoma, etc. HCC and CCC comprise the majority 
of these tumors. Adenosquamous carcinoma (ASC) 
comprises both adenocarcinoma and squamous cell 
carcinoma components. Primary hepatic ASC is con-
sidered a variant CCC subtype. Hepatic ASC is ex-
tremely rare, whereas ASC is common in the 
gallbladder, pancreas, stomach, thyroid, and large in-
testine[1]. 
Hepatic ASC has very poor prognosis. It has no 
specific serum marker and imaging studies for diag-
nosis. A correct diagnosis is difficult to achieve ini-
tially. Moreover, primary hepatic ASC with peritoneal 
carcinomatosis presenting as liver abscess is extreme-
ly rare. Herein, we reported an uncommon presenta-
tion of primary hepatic ASC with peritoneal carcino-
matosis presenting as liver abscess. 
 
CASE REPORT 
A woman (age = 76 years) experienced epigastric 
pain and abdominal fullness for half a month. She had 
a medical history of type 2 diabetes mellitus, hyper-
tension, and sciatica and took oral medication for an 
underlying disease. She had neither a specific family 
history nor a history of smoking and drinking. She 
initially visited a local hospital for treatment where 
physical examination was unremarkable. Esoph-
agogastroduodenoscopy (EGD) revealed one small 
gastric ulcer; abdominal ultrasonography (US) re-
vealed a mild fatty liver. Because of deteriorating ab-
dominal symptoms, she was transferred to our clinic  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Abdominal ultrasound showed multiple 
isoechoic to hypoecohic hepatic lesions 
(arrow) 
 
 
for further evaluation. EGD revealed one small gastric 
ulcer; abdominal US revealed some isoechoic to hy-
poechoic lesions on both the hepatic lobes (Figure 1) 
with mild ascites. She was admitted.  
On admission, she was chronic ill; systemic ex-
amination revealed no abnormalities. Urinalysis re-
vealed pyuria, 32 cells/high power field (normal range 
0-5 cells/high power field). Chest radiography re-
vealed minimal right pleural effusion. Blood tests 
showed leukocytosis, 11200 count/μL (normal range 
4000-10000 count/μL); elevated C-reactive protein 
(CRP) levels, 10.73 mg/dL (normal range < 0.8 
mg/dL). Considering leukocytosis with high CRP lev-
els, pyuria, image of US, and low grade fever (body 
temperature, 37.6°C) on admission day 3, liver ab-
scess or another infectious disease was initially sus-
pected; empirical intravenous flomoxef was pre-
scribed. 
Because we couldn’t rule out metastatic tumors 
completely according to the abdominal US image, we 
conducted some examinations for tumor survey.  
Consequently, tumor marker tests showed elevated 
carcinoembryonic antigen, 43.78 ng/mL (normal range, 
< 5 ng/mL); elevated carbohydrate antigen 19-9 (CA 
19-9), 6030 U/mL (normal range, < 37 U/mL); and  
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Figure 2. Abdominal computed tomography showing 
(A) a largest hypodense lesion in S4 of liver 
with faint rim enhancement, about 7 cm in 
size. (B) a lobulated soft tissue nodule 
measuring about 2 cm in size along the celiac 
axis. (C) a soft tissue nodule abutting the 
anterior peritoneum 
elevated carbohydrate antigen 125, 727 U/ml (normal 
range, < 35 U/ml). Abdominal computed tomography 
(CT) revealed multifocal hypodense lesions with faint 
rim enhancement on both hepatic lobes  (predomi-
nately at S4 of liver, 4 x 7cm), mesenteric lymphade-
nopathy (LAP) along the celiac axis, moderate ascites, 
bilateral pleural effusion, soft tissue nodules abutting 
the anterior peritoneum, and normal pancreatic pa-
renchyma (Figure 2). Considering negative bacterial 
culture results, including blood, urine, ascites, pleural 
effusion, and elevated tumor markers, aforementioned 
CT findings were initially suggestive of hepatic me-
tastases of the tumor. Lung CT and total colonoscopy 
were inconclusive. Gynecologic US showed no ma-
lignant lesions; Papanicolaou smear showed no ma-
lignant cells. Cytology and cell blocks of ascites 
showed malignant cells. Cytology of pleural effusion 
showed atypia. 
Clinical workup and imaging studies failed to 
show any other primary site for malignancy. US- 
guided biopsy was consistent with carcinoma with 
both glandular and squamous differentiation, indicat-
ing the differential diagnosis of the adenosquamous 
variant of CCC and metastatic ASC (Figure 3). Based 
on systemic examination, imaging study, and hepatic 
pathology, primary hepatic ASC (stage IVB with in-
trahepatic and extrahepatic metastases) was diagnosed. 
Thereafter, she received chemotherapy with cisplatin 
and 5-fluorouracil (5-FU). Because of rapid multiple 
organ failure development, this patient died 1 month 
after the diagnosis. 
 
DISCUSSION 
Currently termed hepatic ASC was previously re-
ferred to as hepatic adenoacanthoma or mucoepider-
moid carcinoma. Hepatic ASC is extremely rare; 
Nakajima et al. described the incidence of hepatic 
CCC as approximately 3%-5%, and that of primary 
hepatic ASC as approximately 2%-3% [2, 3]. 
ASC is an adenocarcinoma with significant 
amounts of squamous carcinomatous components that  
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Figure 3. Microscopic findings of primary hepatic adenosquamous carcinoma. (A) (hematoxylin and eosin stain, 
200X). Irregular groups of malignant cells with small mucin glandular spaces (arrow) were noted. (B) 
(hematoxylin and eosin stain, 400X). Squamous tumor cells with intercellular bridges (arrow) was  
noted 
 
 
should be distinguished from adenoacanthoma and 
mucoepidermoid carcinoma [4,5]. Since 1971, less 
than 100 cases have been found using MEDLINE 
search. Histologic features of ASC include an infil-
trating neoplasm with solid and glandular areas. Ma-
lignant squamous differentiation is characterized by 
individual cell keratinization, intercellular bridge, ker-
atin pearl formation and/or dyskeratosis. Malignant 
glandular differentiation is characterized by various- 
sized gland formations and intracellular and intralu-
minal mucin [6]. In our case, microscopically, sections 
of the liver revealed irregular groups of malignant 
cells (immunostaining was positive for CK7) with 
small mucin glandular spaces (Figure 4). Squamous 
tumor cells (immunostaining was positive for p63) 
with intercellular bridges were also found. Im-
munostaining of neoplastic cells were negative for 
CD20, HepPar-1, ER, and TTF-1. Findings were con-
sistent with carcinoma with both glandular and squa-
mous differentiation. Based on histological and im-
munohistochemical findings, the adenosquamous var-
iant of cholangiocarcinoma and metastatic adenosqua-
mous carcinoma should be considered. Because this 
patient had no other primary malignancy, primary he-
patic ASC was finally diagnosed. 
Despite two major theories being proposed, the 
histogenesis of hepatic ASC still remains unclear. One 
is that continuous irritations from chronic inflamma-
tion, such as hepatolithiasis, or infection may induce 
metaplastic changes in the bile duct’s epithelium or 
congenital cysts in the biliary tract leading to neo-
plasia [7-9]. An alternative theory suggests that hepat-
ic ASC arises from the squamous metaplasia of ade-
nocarcinoma [2,5,10-14]. According to this proposal, 
if metaplastic squamous epithelium does undergo ma-
lingnant transformation, the tumor tissue may com-
prise normal epithelium, but most ASC tissue com-
prises squamous cell carcinoma and adenocarcinoma 
cells. According to a study of 12 hepatic ASC patients 
and 29 reviewed cases, Yeh et al. speculated that 
hepatolithiasis may influence the malignant transfor-
mation underlying the squamous metaplasia of CCC, 
which may explain the pathogenesis in most hepatic 
ASC cases [10]. Our patient had no history of hepato-
lithiasis, liver abscess, biliary tract infection, or others 
factors inducing chronic inflammation of her biliary  
A B 
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Figure 4. Immunohistochemistry stain of primary he-
patic adenosquamous carcinoma. (A) The 
cells had strong positive for CK7. (B) The 
cells had positive for mucin (arrow). (C) 
The cells had focally positive for p63 
tract. Thus, her hepatic ASC may have arisen from the 
squamous metaplasia of adenocarcinoma. 
Based on a study of 65 patients [2,10,15], primary 
hepatic ASC occured two-fold more in men (mean age 
= 62.4 years). Initial symptoms included abdominal 
pain, jaundice, fever, anorexia, and weight loss. Ab-
dominal pain (53.1%), fever (25%), and jaundice 
(14.1%) were the three most frequent symptoms of 
primary hepatic ASC. Furthermore, the incidence of 
intrahepatic metastasis of hepatic ASC was high (72% 
in 30 cases of surgically treated primary hepatic ASC) 
[15]. Our patient’s abdominal discomfort followed by 
fever during hospitalization was nonspecific but com-
patible with this investigation. 
Regarding imaging studies, few reports speculate 
that cystic change, bleeding, or necrosis are ASC fea-
tures [16]. Ono et al. reviewed images of 45 primary 
hepatic ASC cases [17]. Abdominal US seemed not 
helpful for better differential diagnosis (33.3% cases, 
hyperechoic; 33.3% cases, hypoechoic; 26.6% cases, 
heterogeneous). According to abdominal CT, 85% of 
cases were found to have low-density lesions. Ac-
cording to magnetic resonance imaging, all cases 
showed low-signal intensity on T1-weighted images; 
83.3% showed high-signal intensity on T2-weighted 
images. Till date, no imaging type could suggest he-
patic ASC with a high specificity. 
Because hepatic ASC is very rare and has no spe-
cific imaging finding or serum marker, most hepatic 
ASCs are diagnosed at autopsy or surgery. Fine needle 
aspiration for cytological study or biopsy is the first 
choice for early differential diagnosis, but diverse di-
agnostic sensitivity and misgiving of peritoneal seed-
ing still make preoperative diagnosis of hepatic ASC 
difficult [18,19]. 
ASC has worse prognosis than common CCC and 
clinically presents more aggressively. The squamous 
cell carcinoma component shows more malignant bi-
ological behavior because of its deoxyribonucleic acid 
aneuploidy patterns and high proliferative activity. 
Consequently, the more the tumor growth, the more 
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the gain in squamous carcinomatous components [16, 
18,20,21]. Poor risk factors include larger tumor di-
ameter (5 cm), primary tumor location in the right 
hepatic lobe, advanced pathologic stage, lymphatic 
permeation, vascular invasion, lymph node metastasis, 
intrahepatic or remote organ metastasis, and postoper-
ative elevation of serum bilirubin levels [2,15,16,18]. 
The mean survival of hepatic ASC was approximately 
few months; few ASC patients survived for more than 
1 year [2,10,15]. In contrast to CCC, 5-year survival 
rates of patients with surgically resected intrahepatic 
CCC were 15%-44% [22]. Our patient had a large 
tumor diameter (7 cm), peritoneal carcinomatosis, and 
intrahepatic metastases with LAP; therefore, we spec-
ulated very poor prognosis. 
Hepatectomy with lymph node dissection, fol-
lowed by adjuvant chemotherapy, is an adequate 
treatment for ASC, but no consensus exists regarding 
transcatheter arterial infusion chemotherapy with em-
bolization, particularly when this hepatic lesion 
showed a hypovascular pattern. Few reports advocate 
radiotherapy. Although no unanimous treatment guide-
line exists for primary hepatic ASC, treatment in-
volves complete tumor resection with lymph node 
dissection or partial tumor resection followed by 
postoperative adjuvant chemotherapy and/or radio-
therapy. In our case, complete tumor resection was not 
feasible because she had intrahepatic and extrahepatic 
metastases and received chemotherapy with cisplatin 
and 5-FU immediately after primary hepatic ASC was 
diagnosed. Because her disease progressed rapidly and 
fulminantly, she died 1 month after the diagnosis. 
CCCs were reported to be the cause of liver ab-
scess in 3.3% of cases in the series by Jan et al [23]. 
We found three primary hepatic ASC cases where pa-
tients presented with fever and were initially diag-
nosed with liver abscess [13,24,25]. All had increased 
CA 19-9 levels. Their US showed different image pat-
tern (a solid liver lesion, complex echoic liver lesion, 
and space-occupying lesion); CT also showed differ-
ent image finding (a hypodense lesion with enhancing 
rim, multiple internal septa, liver lesion with peripher-
al enhancement, and liver lesion with central and pe-
ripheral necrosis). Based on these cases presenting as 
liver abscess, initial complaints were all fever, the 
imaging study revealed suspected liver abscess, and 
their laboratory data showed elevated serum CA 19-9 
levels, findings compatible with those of our patient. 
It is difficult to make correct diagnosis initially 
depending on their initial symptoms and imaging 
studies, but elevated serum CA 19-9 levels are sug-
gestive that these patients may have had other disease 
other than liver abscess alone. For example, if a case 
was initially treated as early liver abscess and the fol-
low-up echo did not show any progressive change 
[26], such as distal acoustic enhancement, diminution 
in the amplitude of the central hepatic lesion, or irreg-
ular echo-poor areas within hepatic lesion, hepatic 
tumor should then be considered. For another example, 
if CT shows low-density lesions at the bilateral hepat-
ic lobe with daughter lesion, not a typical finding of 
liver abscess, hepatic tumor should also be considered. 
 
CONCLUSIONS 
Primary hepatic ASC is a rare disease with very 
poor prognosis that can occasionally erroneously be 
diagnosed as other hepatic tumors such as CCC. Pri-
mary hepatic ASC is usually diagnosed at autopsy or 
postoperatively. Primary hepatic ASC has a high inci-
dence of intrahepatic metastases and may be misdiag-
nosed as liver abscess when the patient has fever, leu-
kocytosis, or high CRP levels. If clinical and imaging 
features are not consistent, biopsy of hepatic lesion is 
suggested. Complete surgical resection with adjuvant 
chemotherapy is currently the first treatment choice 
for primary hepatic ASC, but recurrence is still high 
because of the tumor’s invasive nature. If complete 
tumor resection is not feasible, systemic chemothera-
py with/without partial tumor resection should be 
considered. 
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